Hygeia Healthcare Holdings Co., Limited logo

Hygeia Healthcare Holdings Co., Limited

6078.HK

HKSEHealthcareMedical - Care Facilities

Latest quote

HK$9.69

−HK$0.04 · -0.41%

Aug 24, 4:08 PM HKT

6078.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Company website

Hygeia Healthcare Holdings Co., Limited (6078.HK) is a prominent oncology healthcare provider primarily operating across the People's Republic of China. The company owns and manages a network of private, for-profit hospitals specializing in comprehensive cancer care. These facilities offer a broad spectrum of services, including diagnostic procedures such as tumor screening and genetic analysis, advanced therapeutic interventions like radiotherapy, surgery, chemotherapy, immunotherapy, and targeted treatments, alongside crucial supportive care including oncology rehabilitation, nutritional guidance, and hospice services. Beyond direct patient care, Hygeia also provides consulting expertise for radiotherapy centers and licenses its specialized SRT (Stereotactic Radiotherapy) equipment, offering ongoing maintenance and technical support for these systems. The company's operations extend to providing hospital and corporate management services, as well as supply chain solutions. By the end of 2021, Hygeia Healthcare had established a significant presence, operating or managing 12 oncology-focused hospitals spread across 9 cities in 7 provinces throughout mainland China. Established in 2009, the company maintains its headquarters in Shanghai, PRC.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
CN
CEO
Yiwen Zhu
Listed since
Jun 29, 2020
Employees
7,906

Market position

Day range

Current HK$9.69

52-week range

Current HK$9.69

Open
HK$9.73
Previous close
HK$9.73
Volume
1.16M
0.43× average
Average volume
2.72M
Average daily volume
Market cap
5.87B HKD
Beta
0.39
Market reference 1
50-day average
HK$9.6216
+0.71% above average
200-day average
HK$11.6691
-16.96% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM)
118.72×
P/B (TTM)
0.76×
P/S (TTM)
1.67×
Dividend yield
0.00%

Profitability & efficiency

Gross margin
25.19%
Operating margin
7.34%
Net margin
1.36%

Financial health

Debt / equity
0.36×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends35%24%13%1%Gross margin, FY2021: 32.16%Gross margin, FY2022: 31.83%Gross margin, FY2023: 31.55%Gross margin, FY2024: 29.35%Gross margin, FY2025: 25.53%Operating margin, FY2021: 25.65%Operating margin, FY2022: 20.87%Operating margin, FY2023: 21.81%Operating margin, FY2024: 18.47%Operating margin, FY2025: 9.81%Net margin, FY2021: 19.07%Net margin, FY2022: 14.92%Net margin, FY2023: 16.75%Net margin, FY2024: 13.46%Net margin, FY2025: 4.10%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 32.16%. Gross margin FY2022 31.83%. Gross margin FY2023 31.55%. Gross margin FY2024 29.35%. Gross margin FY2025 25.53%. Operating margin FY2021 25.65%. Operating margin FY2022 20.87%. Operating margin FY2023 21.81%. Operating margin FY2024 18.47%. Operating margin FY2025 9.81%. Net margin FY2021 19.07%. Net margin FY2022 14.92%. Net margin FY2023 16.75%. Net margin FY2024 13.46%. Net margin FY2025 4.10%.

Income trends

Revenue

4.01B HKD-9.84%

Operating income

393.43M HKD-52.09%

Net income

164.53M HKD-72.50%
Income trends across reported periods4.87B HKD3.16B HKD1.45B HKD−263.63M HKDRevenue, FY2021: 2.32B HKDRevenue, FY2022: 3.2B HKDRevenue, FY2023: 4.08B HKDRevenue, FY2024: 4.45B HKDRevenue, FY2025: 4.01B HKDOperating income, FY2021: 593.78M HKDOperating income, FY2022: 666.82M HKDOperating income, FY2023: 889.1M HKDOperating income, FY2024: 821.14M HKDOperating income, FY2025: 393.43M HKDNet income, FY2021: 441.46M HKDNet income, FY2022: 476.78M HKDNet income, FY2023: 682.93M HKDNet income, FY2024: 598.26M HKDNet income, FY2025: 164.53M HKDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 2.32B HKD. Revenue FY2022 3.2B HKD. Revenue FY2023 4.08B HKD. Revenue FY2024 4.45B HKD. Revenue FY2025 4.01B HKD. Operating income FY2021 593.78M HKD. Operating income FY2022 666.82M HKD. Operating income FY2023 889.1M HKD. Operating income FY2024 821.14M HKD. Operating income FY2025 393.43M HKD. Net income FY2021 441.46M HKD. Net income FY2022 476.78M HKD. Net income FY2023 682.93M HKD. Net income FY2024 598.26M HKD. Net income FY2025 164.53M HKD.
Metric (HKD)FY2025FY2024FY2023FY2022FY2021
Revenue4.01B HKD4.45B HKD4.08B HKD3.2B HKD2.32B HKD
Cost of goods sold2.99B HKD3.14B HKD2.79B HKD2.18B HKD1.57B HKD
Gross profit1.02B HKD1.31B HKD1.29B HKD1.02B HKD744.66M HKD
Research and development10.05M HKD
Selling, general, and administrative469.56M HKD424.94M HKD462.75M HKD292.95M HKD225.42M HKD
Operating expenses630.05M HKD483.96M HKD397.15M HKD356.19M HKD150.88M HKD
Interest income3.26M HKD1.51M HKD10.15M HKD17.32M HKD2.16M HKD
Interest expense69.15M HKD71.84M HKD43.17M HKD34.88M HKD23.09M HKD
Depreciation and amortization267.68M HKD180.56M HKD210.54M HKD132.66M HKD98.06M HKD
Operating income393.43M HKD821.14M HKD889.1M HKD666.82M HKD593.78M HKD
Net income164.53M HKD598.26M HKD682.93M HKD476.78M HKD441.46M HKD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
25%
2 beats, 6 misses, 0 met estimates
Average EPS surprise
-9.42%
8 comparable reports
Latest EPS result
-0.14
Estimate -0.13 · Miss by 8.33%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.780.450.12-0.21Q1 '23MissQ3 '23MissQ1 '24BeatQ3 '24MissQ1 '25MissQ3 '25BeatQ1 '26MissQ3 '26Estimate
Q1 2023, reported Mar 20, 2023: actual 0.464, estimate 0.543, surprise -14.53%, Miss. Q3 2023, reported Aug 29, 2023: actual 0.573, estimate 0.584, surprise -1.88%, Miss. Q1 2024, reported Mar 26, 2024: actual 0.605, estimate 0.594, surprise +1.85%, Beat. Q3 2024, reported Aug 29, 2024: actual 0.655, estimate 0.709, surprise -7.62%, Miss. Q1 2025, reported Mar 27, 2025: actual 0.362, estimate 0.702, surprise -48.45%, Miss. Q3 2025, reported Aug 28, 2025: actual 0.465, estimate 0.427, surprise +8.82%, Beat. Q1 2026, reported Mar 30, 2026: actual -0.145, estimate -0.134, surprise -8.33%, Miss. Q3 2026, reported Aug 27, 2026: actual —, estimate 0.346, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates2.98B2.58B2.18B1.78BQ1 '23MissQ3 '23MissQ1 '24MissQ3 '24MissQ1 '25MissQ3 '25MissQ1 '26MissQ3 '26Estimate
Q1 2023, reported Mar 20, 2023: actual 1.89B HKD, estimate 1.93B HKD, surprise -2.28%, Miss. Q3 2023, reported Aug 29, 2023: actual 1.9B HKD, estimate 1.98B HKD, surprise -4.08%, Miss. Q1 2024, reported Mar 26, 2024: actual 2.55B HKD, estimate 2.55B HKD, surprise -0.05%, Miss. Q3 2024, reported Aug 29, 2024: actual 2.56B HKD, estimate 2.86B HKD, surprise -10.48%, Miss. Q1 2025, reported Mar 27, 2025: actual 2.2B HKD, estimate 2.87B HKD, surprise -23.32%, Miss. Q3 2025, reported Aug 28, 2025: actual 2.18B HKD, estimate 2.19B HKD, surprise -0.56%, Miss. Q1 2026, reported Mar 30, 2026: actual 2.25B HKD, estimate 2.27B HKD, surprise -0.80%, Miss. Q3 2026, reported Aug 27, 2026: actual —, estimate 2.37B HKD, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

HK$0.1636

2023 complete year+13.6% since 2021

Corporate action history

Dividend

Ex-dividend Jun 30, 2023

HK$0.1636

Irregular

Record Jul 3, 2023 · Payment Jul 27, 2023

Dividend

Ex-dividend Jun 30, 2021

HK$0.1441

Irregular

Record Jul 5, 2021 · Payment Jul 26, 2021

6078.HK peers

ETFs holding 6078.HK

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research 6078.HK

research.disclaimer